These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 9436697)
21. The relationship between endometrial thickness and pregnancy rates in GnRH antagonist down-regulated ICSI cycles. Kinay T; Tasci Y; Dilbaz S; Cinar O; Demir B; Haberal A Gynecol Endocrinol; 2010 Nov; 26(11):833-7. PubMed ID: 20504095 [TBL] [Abstract][Full Text] [Related]
22. Endometrial wave direction switch and the outcome of in vitro fertilization. IJland MM; Hoogland HJ; Dunselman GA; Lo CR; Evers JL Fertil Steril; 1999 Mar; 71(3):476-81. PubMed ID: 10065785 [TBL] [Abstract][Full Text] [Related]
23. Endometrial pattern, thickness and growth in predicting pregnancy outcome following 3319 IVF cycle. Zhao J; Zhang Q; Wang Y; Li Y Reprod Biomed Online; 2014 Sep; 29(3):291-8. PubMed ID: 25070912 [TBL] [Abstract][Full Text] [Related]
24. [Endometrial thickness in in vitro fertilization. A study of 414 cases]. Kehila M; Kebaili S; Bougmiza I; Meddeb S; Boughizane S; Khairi H; Ajina M Tunis Med; 2010 Dec; 88(12):928-32. PubMed ID: 21136363 [TBL] [Abstract][Full Text] [Related]
25. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles. Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG Hum Reprod; 2016 Aug; 31(8):1859-65. PubMed ID: 27301360 [TBL] [Abstract][Full Text] [Related]
26. Endometrial thickness as a predictor of pregnancy after in-vitro fertilization but not after intracytoplasmic sperm injection. Rinaldi L; Lisi F; Floccari A; Lisi R; Pepe G; Fishel S Hum Reprod; 1996 Jul; 11(7):1538-41. PubMed ID: 8671501 [TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of endometrial evaluation by ultrasonography in ovulation induced cycles. Idriss WK; Mohiuddin MA; Zachariah M; Sambasiva K Saudi Med J; 2000 Nov; 21(11):1059-64. PubMed ID: 11360069 [TBL] [Abstract][Full Text] [Related]
28. Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization. Balasch J; Fábregues F; Creus M; Moreno V; Puerto B; Peñarrubia J; Carmona F; Vanrell JA Hum Reprod; 1996 Nov; 11(11):2400-4. PubMed ID: 8981119 [TBL] [Abstract][Full Text] [Related]
29. The effect of endometrial thickness and pattern measured by ultrasonography on pregnancy outcomes during IVF-ET cycles. Zhao J; Zhang Q; Li Y Reprod Biol Endocrinol; 2012 Nov; 10():100. PubMed ID: 23190428 [TBL] [Abstract][Full Text] [Related]
30. Influence of gonadotrophin-releasing hormone agonist total dose in the ovarian stimulation in the long down-regulation protocol for in-vitro fertilization. Alvarez C; Cremades N; Blasco N; Bernabeu R Hum Reprod; 1997 Nov; 12(11):2366-9. PubMed ID: 9436664 [TBL] [Abstract][Full Text] [Related]
31. Assessment of endometrial receptivity for gestation in patients undergoing in vitro fertilization, using endometrial thickness and the endometrium-myometrium relative echogenicity coefficient. Leibovitz Z; Grinin V; Rabia R; Degani S; Shapiro I; Tal J; Eibschitz I; Harari O; Paltieli Y; Aharoni A; Zeevi J; Ohel G Ultrasound Obstet Gynecol; 1999 Sep; 14(3):194-9. PubMed ID: 10550880 [TBL] [Abstract][Full Text] [Related]
32. Changes in endometrial thickness, width, length and pattern in predicting pregnancy outcome during ovarian stimulation in in vitro fertilization. Bassil S Ultrasound Obstet Gynecol; 2001 Sep; 18(3):258-63. PubMed ID: 11555457 [TBL] [Abstract][Full Text] [Related]
33. Ultrasonographic appearance of the endometrium in natural and stimulated in-vitro fertilization cycles and its correlation with outcome. Ueno J; Oehninger S; Brzyski RG; Acosta AA; Philput CB; Muasher SJ Hum Reprod; 1991 Aug; 6(7):901-4. PubMed ID: 1761655 [TBL] [Abstract][Full Text] [Related]
34. Subcutaneous low dose leuprolide acetate depot versus leuprolide acetate for women undergoing ovarian stimulation for in-vitro fertilization. Tsai HD; Chen CM; Lo HY; Chang CC Hum Reprod; 1995 Nov; 10(11):2909-12. PubMed ID: 8747042 [TBL] [Abstract][Full Text] [Related]
35. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women. Westergaard LG; Erb K; Laursen S; Rasmussen PE; Rex S Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425 [TBL] [Abstract][Full Text] [Related]
37. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders. Lainas TG; Sfontouris IA; Venetis CA; Lainas GT; Zorzovilis IZ; Tarlatzis BC; Kolibianakis EM Hum Reprod; 2015 Oct; 30(10):2321-30. PubMed ID: 26307091 [TBL] [Abstract][Full Text] [Related]
38. Effect of letrozole at 2.5 mg or 5.0 mg/day on ovarian stimulation with gonadotropins in women undergoing intrauterine insemination. Noriega-Portella L; Noriega-Hoces L; Delgado A; Rubio J; Gonzales-Castañeda C; Gonzales GF Fertil Steril; 2008 Nov; 90(5):1818-25. PubMed ID: 18083169 [TBL] [Abstract][Full Text] [Related]
39. Sonographic assessment of endometrial pattern and thickness in patients treated with human menopausal gonadotropins. Bohrer MK; Hock DL; Rhoads GG; Kemmann E Fertil Steril; 1996 Aug; 66(2):244-7. PubMed ID: 8690110 [TBL] [Abstract][Full Text] [Related]
40. Influence of serum follicle stimulating hormone to luteinizing hormone ratio during buserelin acetate-induced pituitary desensitization on ovarian response to exogenous gonadotrophins in an in-vitro fertilization and embryo transfer programme. Yamashita T; Ishimaru T; Fujishita A; Kawano M; Yamabe T Hum Reprod; 1996 Aug; 11(8):1615-9. PubMed ID: 8921103 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]